The USFDA has just approved Pfizer Animal Health’s Slentrol™ for the safe and effective management of canine obesity, making it the first and only veterinary-approved obesity drug for dogs in the United States.
According to Claudia A. Kirk, DVM, PhD, Associate Professor of Medicine and Nutrition, College of Veterinary Medicine, University of Tennessee:
"Why are 40 percent of dogs in the U.S. overweight or obese? The answer is simple: Too much food and too little exercise. In today's hectic world, it's a challenge for many dog owners to find time to ensure their pets get adequate exercise.
And in our culture, we often equate food with love - without being aware of potential adverse health consequences. For both pet owners and veterinarians trying to manage a dog's weight, these habits can be a source of genuine frustration."
Slentrol™works by decreasing a dog's appetite thereby reducing food intake and making it easier for owners to develop healthier feeding behaviours and attitudes.
A prescription drug (will be available only through veterinarians starting this spring), Slentrol is given once daily as an oral solution” either directly into the mouth or with a small amount of food.
Source: PR Newswire
Comment Preview